Publication AWA
At the Public Information Bulletin of the Agency for Health Technology Assessment and Tarification (AWA) has published reviews analyses for the evaluation of reimbursement applications:
- PKU GMPro Mix In for dietary management in patients with phenylketonuria over 3 years of age
- Bimzelx, bimekizumabum for the treatment of patients with suppurative apocrine hidradenitis (HS)
We encourage you to read the full documents and submit comments within the prescribed period of 7 days from the date of publication.
